文献速递传染病防控与疫情报告免疫规划

疫苗接种人群新型冠状病毒感染聚集性疫情的流行病学特征及血清抗体检测

[Epidemiological characteristics and serum antibody detection of a COVID-19 aggregated outbreak in vaccinated population].
PubMed 文献 · Zhonghua Yu Fang Yi Xue Za Zhi · 2023-01-01

对北京市2022年一起疫苗接种人群新冠感染聚集性疫情开展流行病学调查,采集21例感染者和61例密切接触者(其中20例隔离观察期核酸转阳)血清标本。结果显示98.78%对象曾接种新冠灭活疫苗,3剂接种者IgG抗体阳性率86.00%(43/50)高于1~2剂者16.12%(5/31),抗体水平亦更高(均P<0.001)。

要点

  • 3剂疫苗接种者IgG抗体阳性率86.00%(43/50),高于1~2剂者16.12%(5/31)(P<0.001)。
  • 末次接种<3个月者抗体水平高于≥3个月者(P=0.007)。
  • 3剂次密接转阳者IgG阳性率77.78%(7/9)高于1~2剂次者0(P<0.05)。

核心结论

  • 疫苗接种人群发生新冠聚集性疫情时,3剂疫苗接种者IgG抗体阳性率和水平均高于1~2剂者,末次接种<3个月者抗体水平更高。

研究设计与样本

  • 对北京市2022年一起新冠疫苗接种人群感染聚集性疫情进行流行病学调查,采集21例感染者和61例密切接触者(其中20例隔离观察期核酸转阳)血清标本。

主要发现

  • 2例感染者IgM抗体阳性,密接转阳者、密接未转阳者和感染者的IgG抗体阳性率分别为36.84%(7/19)、63.41%(26/41)和71.43%(15/21)。
  • 98.78%的对象曾接种新冠灭活疫苗,3剂疫苗接种者IgG抗体阳性率为86.00%(43/50),高于1~2剂者16.12%(5/31);3剂接种者抗体水平M(Q1,Q3)为4.255(2.303,7.0375),高于1~2剂者0.500(0.500,0.500)(均P<0.001)。
  • 末次接种时间<3个月者抗体水平M(Q1,Q3)为7.335(1.909,7.858),高于≥3个月者2.125(0.500,4.418)(P=0.007)。
  • 3剂次密接转阳者IgG抗体阳性率和抗体水平M(Q1,Q3)分别为77.78%(7/9)和4.207(2.216,7.099),均高于1~2剂次者0和0.500(0.500,0.500)(均P<0.05)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

An epidemiological investigation was conducted on a cluster epidemic of COVID-19 in the vaccinated population in Beijing in 2022, and serum samples were collected from 21 infected cases and 61 close contacts (including 20 cases with positive nucleic acid in the isolation observation period). The results of antibody detection showed that the IgM antibody of two infected persons was positive, and the IgG antibody positive rates of patients who were converted, not converted to positive and infected persons were 36.84% (7/19), 63.41% (26/41) and 71.43% (15/21), respectively. About 98.78% of patients had been vaccinated with the SARS-CoV-2 inactivated vaccine. The positive rate of IgG antibody in patients immunized with three doses of vaccine was 86.00% (43/50), which was higher than that in patients with one or two doses [16.12% (5/31)]. The antibody level of M (Q1, Q3) in patients immunized with three doses was 4.255 (2.303, 7.0375), which was higher than that in patients with one or two doses [0.500 (0.500, 0.500)] (all P values<0.001). The antibody level of patients who were vaccinated less than three months [7.335 (1.909, 7.858)] was higher than that of patients vaccinated more than three months after the last vaccination [2.125 (0.500, 4.418)] (P=0.007). The positive rate and level of IgG antibody in patients who were converted to positive after three doses were 77.78% (7/9) and 4.207 (2.216, 7.099), respectively, which were higher than those in patients who were converted after one or two doses [0 and 0.500 (0.500, 0.500)] (all P values<0.05). 对北京市2022年一起新型冠状病毒疫苗接种人群新型冠状病毒感染聚集性疫情进行流行病学调查,并采集21例感染者和61例密切接触者血清标本(其中20例隔离观察期核酸转阳)。抗体检测结果显示:2例感染者IgM抗体阳性,密接转阳者、密接未转阳者和感染者的IgG抗体阳性率分别为36.84%(7/19)、63.41%(26/41)和71.43%(15/21)。98.78%的对象曾接种新型冠状病毒灭活疫苗,3剂疫苗接种者IgG抗体阳性率为86.00%(43/50),高于1~2剂者[16.12%(5/31)];3剂接种者抗体水平[M(Q1,Q3)为4.255(2.303,7.0375)]高于1~2剂接种者[M(Q1,Q3)为0.000(0.000,0.000)](均P<0.001)。末次接种时间<3个月者抗体水平M(Q1,Q3)为7.335(1.909,7.858),高于接种时间≥3个月者[M(Q1,Q3)为2.125(0.000,4.418)](P=0.007)。3剂次密接转阳者IgG抗体阳性率和抗体水平M(Q1,Q3)分别为77.78%(7/9)和4.207(2.216,7.099),均高于1~2剂次者[分别为0和0.000(0.000,0.000)](均P<0.05)。.

来源:Zhonghua Yu Fang Yi Xue Za Zhi,查看原文。版权归原作者所有。

引用

  1. Ren ZY, Gong HY, Xin D, et al. [Epidemiological characteristics and serum antibody detection of a COVID-19 aggregated outbreak in vaccinated population]. Zhonghua Yu Fang Yi Xue Za Zhi. 2023. PMID: 37165819. doi:10.3760/cma.j.cn112150-20220627-00659

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。